Previous close | 18.89 |
Open | 19.27 |
Bid | 0.00 x 3100 |
Ask | 0.00 x 800 |
Day's range | 17.52 - 20.38 |
52-week range | 0.86 - 24.44 |
Volume | 6,517,673 |
Avg. volume | 4,981,411 |
Market cap | 1.007B |
Beta (5Y monthly) | 2.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.73 |
Earnings date | 09 Nov 2020 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.25 |
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today provided an update on recent warrant exercises and the resulting impact on its cash position.
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that the Company will be participating as a speaker in Verizon's upcoming "5G Innovation Sessions; Advancing the Mission of the DOD" event taking place Wednesday February 24, 2021 at 2 PM EST. In this hour-long session, Verizon will explain why 5G matters to the U.S. Department of Defense, how it can help securely shape missions and discuss defense-focused use cases.
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that the Company's Vuzix M400 Smart Glasses were featured in the American Medical Association's Special COVID-19 Edition for Accelerating Change in Medical Health Education Systems Science Student, Resident and Fellow Impact Challenge. The clinical study was conducted by the University of Louisville School of Medicine and summarized in the recent publication by the American Medical Association.